Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Summary

The purpose of this study is to examine tolerability, safety, and pharmacokinetics of YS110 intravenous administration in patients with malignant pleural mesothelioma and to preliminarily examine the anti-tumor effect of YS110.

Timeline

Start

2017-08-08

Primary completion

2020-02-05

Completion

2020-02-05

Drugs

Indications